Search results

|title=Schneeberger M, Gómez-Valadés AG, Altirriba J, Sebastián D, Ramírez S, Garcia A, Esteban Y, Drougard A, Fe |authors=Schneeberger M, Gomez-Valades AG, Altirriba J, Sebastian D, Ramirez S, Garcia A, Esteban Y, Drougard A, Ferr

|title=Ramírez S, Gómez-Valadés AG, Schneeberger M, Varela L, Haddad-Tóvolli R, Altirriba J, Noguera E, Droug |authors=Ramirez S, Gomez-Valades AG, Schneeberger M, Varela L, Haddad-Tovolli R, Altirriba J, Noguera E, Drouga

|title=Gómez-Valadés AG, Pozo M, Varela L, Boudjadja MB, Ramírez S, Chivite I, Eyre E, Haddad-Tóv |authors=Gomez-Valades Alicia G, Pozo Macarena, Varela Luis, Boutagouga Boudjadja Mehdi, Ramirez S

|'''CH Novartis Pharma AG''' |'''CH Novartis Pharma AG (CH)'''

:::# Mounsey, R. B. et al. (2015) ‘Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mous

:::: '''5a.6. Ref 287''' Chi SC, Cheng HC, Wang AG (2022) Leber hereditary optic neuropathy: molecular pathophysiology and upd ...Iuso A, Bouchereau J, Kremer LS, Paviolo M, Terrile C, Bénit P, Rasmusson AG, Schwarzmayr T, Tiranti V, Rustin P, Rak M, Prokisch H, Schiff M (2019) Ara